nach oben

Inflammation

Erschienen in:

15.06.2022 | Original Article

Effects of Resveratrol on Tight Junction Proteins and the Notch1 Pathway in an HT-29 Cell Model of Inflammation Induced by Lipopolysaccharide

verfasst von: Yihua Luo, Xueyan Yu, Peizhuang Zhao, Jun Huang, Xue Huang

Erschienen in: Inflammation | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Ulcerative colitis (UC) is closely associated with disruption of intestinal epithelial tight junction proteins. A variety of studies have confirmed that resveratrol (RSV), a natural polyphenolic compound, has a potential anti-inflammatory effect and can regulate the expression of tight junction proteins. However, the mechanism by which RSV regulates the expression of tight junction proteins in the intestinal epithelium remains unclear. Therefore, we investigated the potential effect of RSV on tight junction proteins in an HT-29 cell model of inflammation induced by lipopolysaccharide (LPS) and explored its mechanism of action. First, the downregulated expression of the tight junction proteins occludin, ZO-1, and claudin-1 in the HT-29 cell model of inflammation induced by LPS was reversed by incubation with RSV, accompanied by a decrease in the expression of tumor necrosis factor α-converting enzyme (TACE). Additionally, the Notch1 pathway was attenuated and the expression of the inflammatory factors IL-6 and TNF-α was decreased by treatment with RSV. Second, after Jagged-1 was used in combination with RSV to reactivate the Notch1 pathway, the protective effects of RSV against the LPS-induced reductions in the expression of the tight junction proteins occludin, ZO-1, and claudin-1 and the decreases in the levels of the inflammatory factors IL-6 and TNF-α were abolished. These results suggest that RSV might regulate the expression of tight junction proteins by attenuating the Notch1 pathway.

Kaplan, G.G. 2015. The global burden of IBD: From 2015 to 2025. Nature Reviews. Gastroenterology & Hepatology 1212: 720–727. https://doi.org/10.1038/nrgastro.2015.150.CrossRef

Porter, R.J., R. Kalla, and G.T Ho. 2020. Ulcerative colitis: recent advances in the understanding of disease pathogenesis. F1000Res 9. https://doi.org/10.12688/f1000research.20805.1.

Schmitz, H., C. Barmeyer, M. Fromm, N. Runkel, H.D. Foss, C.J. Bentzel, E.O. Riecken, and J.R. Dschulzke. 1999. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 1162: 301–309. https://doi.org/10.1016/s0016-5085(99)70126-5.CrossRef

Chelakkot, C., J. Ghim, and S.H. Ryu. 2018. Mechanisms regulating intestinal barrier integrity and its pathological implications. Experimental & Molecular Medicine 508: 1–9. https://doi.org/10.1038/s12276-018-0126-x.CrossRef

Ghorbaninejad, M., R. Heydari, P. Mohammadi, S. Shahrokh, M. Haghazali, B. Khanabadi, and A. Meyfour. 2019. Contribution of NOTCH signaling pathway along with TNF-alpha in the intestinal inflammation of ulcerative colitis. Gastroenterol Hepatol Bed Bench 12Suppl1: S80-S86.

Gersemann, M., S. Becker, I.K. Bler, M. Koslowski, G. Wang, K.R. Herrlinger, J. Griger, P. Fritz, K. Fellermann, and M. Schwab. 2009. Differences in goblet cell differentiation between Crohn’s disease and ulcerative colitis. Differentiation 771: 84–94. https://doi.org/10.1016/j.diff.2008.09.008.CrossRef

Gordon, W.R., K.L. Arnett, and S.C. Blacklow. 2008. The molecular logic of Notch signaling—a structural and biochemical perspective. J Cell Sci 121Pt 19: 3109–3119. https://doi.org/10.1242/jcs.035683.

Wan, Y., and Z.Q. Yang. 2020. LncRNA NEAT1 affects inflammatory response by targeting miR-129–5p and regulating Notch signaling pathway in epilepsy. Cell Cycle 194: 419–431. https://doi.org/10.1080/15384101.2020.1711578.

Hui, Y., S.G. Yan, and Q. Wang. 2020. Effects of 6-Shogaol on Notch signaling pathway in colonic epithelial cells of ulcerative colitis mice. Zhongguo Ying Yong Sheng Li Xue Za Zhi 361: 90–93. https://doi.org/10.12047/j.cjap.5889.2020.020.

10.

Lin, J.C., J.Q. Wu, F. Wang, F.Y. Tang, J. Sun, B. Xu, M. Jiang, Y. Chu, D. Chen, and X. Li. 2019. QingBai decoction regulates intestinal permeability of dextran sulphate sodium-induced colitis through the modulation of notch and NF-kappaB signalling. Cell Proliferation 522: e12547. https://doi.org/10.1111/cpr.12547.CrossRef

11.

Zhao, Y., H. Luan, H. Gao, and X. Wu,Y Zhang, and R. Li. 2020. Gegen Qinlian decoction maintains colonic mucosal homeostasis in acute/chronic ulcerative colitis via bidirectionally modulating dysregulated Notch signaling. Phytomedicine 68: 153182. https://doi.org/10.1016/j.phymed.2020.153182.CrossRefPubMed

12.

Zong, D.D., X.M. Liu, J.H. Li, R.Y. Ouyang, Y.J. Long, P. Chen, and Y. Chen. 2021. Resveratrol attenuates cigarette smoke induced endothelial apoptosis by activating Notch1 signaling mediated autophagy. Respiratory Research 221: 22. https://doi.org/10.1186/s12931-021-01620-3.CrossRef

13.

Kim, T.H., J.H. Park, and J.S. WO. 2019. Resveratrol induces cell death through ROS-dependent downregulation of Notch1/PTEN/Akt signaling in ovarian cancer cells. Molecular Medicine Reports 194: 3353–3360. https://doi.org/10.3892/mmr.2019.9962.CrossRef

14.

Santos, M.A., F.N. Franco, C.A. Caldeira, G.R.D. Araújo, A. Vieira, and M.M. Chaves. 2021. Antioxidant effect of resveratrol: Change in MAPK cell signaling pathway during the aging process. Archives of Gerontology and Geriatrics 92: 104266. https://doi.org/10.1016/j.archger.2020.104266.CrossRefPubMed

15.

Zhang, Q., H. Huang, F. Zheng, H. Liu, F. Qiu, Y. Chen, C. Liang, and Z. Dai. 2020. Resveratrol exerts antitumor effects by downregulating CD8(+)CD122(+) Tregs in murine hepatocellular carcinoma. Oncoimmunology 91: 1829346. https://doi.org/10.1080/2162402X.2020.1829346.CrossRef

16.

Salla, M., V. Pandya, K.S. Bhullar, E. Kerek, Y.F. Wong, R. Losch, J. Ou, F.S. Aldawsari, C. Velazquez-Martinez, and A. Thiesen. 2020. Resveratrol and resveratrol-aspirin hybrid compounds as potent intestinal anti-inflammatory and anti-tumor drugs. Molecules 2517. https://doi.org/10.3390/molecules25173849.

17.

Samsamikor, M., N.E. Daryani, P.R. Asl, and H. Azita. 2016. Resveratrol supplementation and oxidative/anti-oxidative status in patients with ulcerative colitis: A randomized, double-blind, placebo-controlled pilot study. Archives of Medical Research 474: 304–309. https://doi.org/10.1016/j.arcmed.2016.07.003.CrossRef

18.

Samsamikor, M., N.E. Daryani, P.R. Asl, and H. Azita. 2015. Anti-inflammatory effects of resveratrol in patients with ulcerative colitis: A randomized, double-blind, placebo-controlled pilot study. Archives of Medical Research 464: 280–285. https://doi.org/10.1016/j.arcmed.2015.05.005.CrossRef

19.

Zhu, F., J. Zheng, F. Xu, Y. Xi, J. Chen, and X. Xu. 2021. Resveratrol alleviates dextran sulfate sodium-induced acute ulcerative colitis in mice by mediating PI3K/Akt/VEGFA pathway. Frontiers in Pharmacology 12: 693982. https://doi.org/10.3389/fphar.2021.693982.CrossRefPubMedPubMedCentral

20.

Liu, B., S. Li, X. Sui, L. Guo, X. Liu, H. Li, L. Gao, S. Cai, Y. Li, T. Wang, and X. Piao. 2018. Root extract of Polygonum cuspidatum Siebold & Zucc. ameliorates DSS-induced ulcerative colitis by affecting NF-kappaB signaling pathway in a mouse model via synergistic effects of polydatin, resveratrol, and emodin. Front Pharmacol 9: 347. https://doi.org/10.3389/fphar.2018.00347.

21.

Pan, H.H., X.X. Zhou, Y.Y. Ma, Y.Y. Ma, W.S. Pan, F. Zhao, M.S. Yu, and J.Q. Liu. 2020. Resveratrol alleviates intestinal mucosal barrier dysfunction in dextran sulfate sodium-induced colitis mice by enhancing autophagy. World Journal of Gastroenterology 2633: 4945–4959. https://doi.org/10.3748/wjg.v26.i33.4945.CrossRef

22.

Rawat, M., M. Nighot, R. Al-Sadi, Y. Gupta, D. Viszwapriya, G. Yochum, W. Koltun, and T.Y. Ma. 2020. IL1B increases intestinal tight junction permeability by up-regulation of MIR200C-3p, which degrades occludin mRNA. Gastroenterology 1594: 1375–1389. https://doi.org/10.1053/j.gastro.2020.06.038.CrossRef

23.

Pochard, C., J. Gonzales, A. Bessard, M.M. Mahe, A. Bourreille, N. Cenac, A. Jarry, E. Coron, J. Podevin, and G. Meurette. 2021. PGI2 inhibits intestinal epithelial permeability and apoptosis to alleviate colitis. Cellular and Molecular Gastroenterology and Hepatology 123: 1037–1060. https://doi.org/10.1016/j.jcmgh.2021.05.001.CrossRef

24.

Ma, Y., J. Yue, Y. Zhang, C. Shi, M. Odenwald, W.G. Liang, Q. Wei, A. Goel, X. Gou, and J. Zhang. 2017. ACF7 regulates inflammatory colitis and intestinal wound response by orchestrating tight junction dynamics. Nature Communications 8: 15375. https://doi.org/10.1038/ncomms15375.CrossRefPubMedPubMedCentral

25.

Mayangsari, Y., and T. Suzuki. 2018. Resveratrol ameliorates intestinal barrier defects and inflammation in colitic mice and intestinal cells. Journal of Agricultural and Food Chemistry 6648: 12666–12674. https://doi.org/10.1021/acs.jafc.8b04138.CrossRef

26.

Brynskov, J., P. Foegh, G. Pedersen, C. Ellervik, T. Kirkegaard, A. Bingham, and T. Saermark. 2002. Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease. Gut 511: 37–43. https://doi.org/10.1136/gut.51.1.37.CrossRef

27.

Yamamoto-Furusho, J.K., E.J. Mendivil-Rangel, and B.G. Fonseca-Camarillo. 2012. Differential expression of occludin in patients with ulcerative colitis and healthy controls. Inflammatory Bowel Diseases 1810: E1999. https://doi.org/10.1002/ibd.22835.CrossRef

28.

Mathern, D., L. Laitman, Z. Hovhannisyan, D. Dunkin, S. Farsio, T. Malik, G. Roda, A. Chitre, A. Iuga, and G. Yeretssian. 2014. Mouse and human Notch-1 regulate mucosal immune responses. Mucosal Immunology 74: 995–1005. https://doi.org/10.1038/mi.2013.118.CrossRef

29.

Kopan, R., and M.X.G. Ilagan. 2009. The canonical Notch signaling pathway: Unfolding the activation mechanism. Cell 1372: 216–233. https://doi.org/10.1016/j.cell.2009.03.045.CrossRef

30.

Zhang, Q., C. Wang, Z. Liu, X. Liu, C. Han, X. Cao, and N. Li. 2012. Notch signal suppresses Toll-like receptor-triggered inflammatory responses in macrophages by inhibiting extracellular signal-regulated kinase 1/2-mediated nuclear factor kappaB activation. Journal of Biological Chemistry 2879: 6208–6217. https://doi.org/10.1074/jbc.M111.310375.CrossRef

31.

Alvarado, D.M., B. Chen, M. Iticovici, A.I. Thaker, N. Dai, K.L. VanDussen, N. Shaikh, C.K. Lim, G.J. Guillemin, P.I. Tarr, and M.A. Ciorba. 2019. Epithelial indoleamine 2,3-dioxygenase 1 modulates aryl hydrocarbon receptor and notch signaling to increase differentiation of secretory cells and alter mucus-associated microbiota. Gastroenterology 1574 (1093–1108): e1011. https://doi.org/10.1053/j.gastro.2019.07.013.CrossRef

32.

Cong, Z., G. Ye, Z. Bian, M.H. Yu, and M. Zhong. 2018. Jagged-1 attenuates LPS-induced apoptosis and ROS in rat intestinal epithelial cells. International Journal of Clinical and Experimental Pathology 118: 3994–4003.

Titel: Effects of Resveratrol on Tight Junction Proteins and the Notch1 Pathway in an HT-29 Cell Model of Inflammation Induced by Lipopolysaccharide
verfasst von: Yihua Luo
Xueyan Yu
Peizhuang Zhao
Jun Huang
Xue Huang
Publikationsdatum: 15.06.2022
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 6/2022
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-022-01704-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Effects of Resveratrol on Tight Junction Proteins and the Notch1 Pathway in an HT-29 Cell Model of Inflammation Induced by Lipopolysaccharide

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2022

Piperlongumin Improves Survival in the Mouse Model of Sepsis: Effect on Coagulation Factors and Lung Inflammation

Modulation of Microglia M2 Polarization and Alleviation of Hippocampal Neuron Injury By MiR-106b-5p/RGMa in a Mouse Model of Status Epilepticus

Inhibition of Dyrk1A Attenuates LPS-Induced Neuroinflammation via the TLR4/NF-κB P65 Signaling Pathway

Gallic Acid Improves Therapeutic Effects of Mesenchymal Stem Cells Derived from Adipose Tissue in Acute Renal Injury Following Rhabdomyolysis Induced by Glycerol

Neutrophil–lymphocyte Ratio and C-Reactive Protein Levels are not Associated with Strength, Muscle Mass, and Functional Capacity in Kidney Transplant Patients

Phenotyping of Fecal Microbiota of Winnie, a Rodent Model of Spontaneous Chronic Colitis, Reveals Specific Metabolic, Genotoxic, and Pro-inflammatory Properties

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin